Health & Education · Leeds and London
NHS to introduce AI blood test for cancer and rapid endometriosis checks, cutting years-long waits
Two separate diagnostic advances promise to spare thousands of women invasive procedures: an AI-powered blood test for gynaecological cancers and two rapid endometriosis tests recommended for GP use.
AI text based on reports by The Independent, The Guardian, BBC and other publishers. Published . How it is made
For membersThe first 30 seconds for everyone. Synthetic voice (AI).
In brief
PinPoint test analyses 30 blood markers with AI, achieving 99% accuracy in trials on over 16,000 patients; could spare 18,000 women a year from invasive scans.
NICE draft guidance recommends Endotest (saliva) and EndoSure (gut electrical signals) for GP use, aiming to cut the average nine-year diagnosis wait.
90,000 women referred annually for post-menopausal bleeding; only 10% have cancer. Endometriosis affects 1 in 10 women, with many waiting over a decade for answers.
NHS trusts in Yorkshire will adopt PinPoint; endometriosis tests will be used under a three-year evaluation period before potential final NICE approval.
Cancer blood test
A new blood test called PinPoint uses artificial intelligence to analyse 30 markers and predict a patient's risk of gynaecological cancer as low, elevated or high. The test, developed by Leeds-based PinPoint Data Science, was assessed in five NHS trusts in Yorkshire on 16,481 cancer referrals, including 2,953 with suspected gynaecological cancer (one source reports 3,313 women referred for possible womb cancer). Results showed a 99% accuracy rate in detecting and ruling out the disease.
Around 90,000 postmenopausal women in England are referred each year for post-menopausal bleeding, yet only about one in 10 have cancer. The PinPoint test, costing around £30, could spare an estimated 18,000 women a year from transvaginal ultrasound scans, which many find uncomfortable or painful.
“If the score is very low, you're at low risk, and actually probably the last thing the patient wants is a load of invasive tests - it is going to be unpleasant, it is a very stressful experience being checked for cancer.”
Mid Yorkshire NHS teaching trust and Leeds teaching hospitals NHS trust plan to start using the test for gynaecological and upper gastrointestinal cancers. Dr Savage said the test also performs well for lung, head and neck, and lower gastrointestinal cancers.
Endometriosis tests
Two non-invasive tests for endometriosis have been recommended in draft guidance by the National Institute for Health and Care Excellence (NICE) for use in GP surgeries in England and Wales. Endotest analyses saliva for microRNA markers, while EndoSure measures electrical signals in the gut via abdominal sensor pads. EndoSure provides results in as little as 45 minutes.
Endometriosis affects around one in 10 women of reproductive age in the UK, but the average diagnosis wait is over nine years, rising to 11 years for ethnically diverse communities. More than half of women surveyed had visited their GP over 10 times before diagnosis, and many had attended A&E.
“A diagnosis of endometriosis can for some women take the best part of a decade, with the UK average standing at nine years and four months. These technologies have the potential to change that by giving primary care professionals better non-invasive tools to identify endometriosis earlier.”
The tests will be available under a three-year evidence-gathering period, with final approval possible afterwards. They are not standalone diagnostics but are intended to speed up referral and treatment.
Patient impact
Patient accounts highlight the toll of delayed diagnosis. Ami Robertson, 23, experienced pain from age 16 but was repeatedly told it was irritable bowel syndrome. Sharan Uppal paid privately for the gut test for her daughter Simran after years of GP visits and A&E trips. The positive result empowered her to push for a referral.
Separately, University of Edinburgh researchers have identified differences in androgen hormones that could lead to a blood test for endometriosis, though that work remains at the research stage.
Ask about this text
Sources and context
- The IndependentNew cancer blood test could spare thousands of patients from gynaecological exams
- The GuardianThousands of women could be spared painful cancer exam by new NHS AI blood test
- BBCGPs to offer two new tests to help spot endometriosis
- RTE.ie'Game changer' tests for endometriosis approved in UK
- Dr Richard Savage
- PinPoint chief scientist
- Prof Sean Duffy
- PinPoint Data Science chief medical officer
- Dr Anastasia Chalkidou
- NICE healthtech programme director
- Ami Robertson
- endometriosis patient diagnosed after years of symptoms
- Sharan Uppal
- mother who sought private endometriosis test for daughter Simran
- Places
- Edinburgh
Pollar is free and carries no ads in the text. Its members keep it going.
Support Pollar